The joint contribution of tumor phenotype and education to breast cancer survival disparity between Hispanic and non-Hispanic white women

[1]  Huang Jun,et al.  Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype , 2014 .

[2]  Katherine E Henson,et al.  Risk of Suicide After Cancer Diagnosis in England , 2018, JAMA psychiatry.

[3]  Deepa Naishadham,et al.  Cancer statistics for Hispanics/Latinos, 2012 , 2012, CA: a cancer journal for clinicians.

[4]  Pierre Goovaerts,et al.  Identifying risk factors for disparities in breast cancer mortality among African-American and Hispanic women. , 2012, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[5]  G. Hortobagyi,et al.  Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers , 2012, Cancer.

[6]  Martin Krapcho,et al.  SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) , 2012 .

[7]  D. Kleinbaum,et al.  Evaluating the Proportional Hazards Assumption , 2012 .

[8]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[9]  T. Byers,et al.  Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women. , 2011, Journal of women's health.

[10]  A. González-Angulo,et al.  Triple‐negative breast cancer in Hispanic patients , 2011, Cancer.

[11]  Yulei He,et al.  The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care , 2011, Cancer.

[12]  A. Neugut,et al.  Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer , 2011, Breast Cancer Research and Treatment.

[13]  T. Byers,et al.  Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors , 2011, Breast Cancer Research and Treatment.

[14]  S. Ooi,et al.  Disparities in breast cancer characteristics and outcomes by race/ethnicity , 2011, Breast Cancer Research and Treatment.

[15]  S. Cole,et al.  Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study , 2010, Clinical Cancer Research.

[16]  S. Edge,et al.  Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Rosenberg,et al.  Method of Detection and Breast Cancer Survival Disparities in Hispanic Women , 2010, Cancer Epidemiology, Biomarkers and Prevention.

[18]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.

[19]  E. Perez,et al.  Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups. , 2010, The oncologist.

[20]  Päivi Heikkilä,et al.  Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies , 2010, PLoS medicine.

[21]  C. Parise,et al.  Variation in breast cancer subtypes with age and race/ethnicity. , 2008, Critical reviews in oncology/hematology.

[22]  T. Eberlein.  Time to Disease Recurrence in Basal-Type Breast Cancers: Effects of Tumor Size and Lymph Node Status , 2010 .

[23]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). , 2010, Archives of pathology & laboratory medicine.

[24]  C. Ulrich,et al.  Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  D. Rose,et al.  The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. , 2009, Journal of women's health.

[26]  Christine B Ambrosone,et al.  Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors , 2009, Breast Cancer Research.

[27]  R. Coates,et al.  The epidemiology of triple-negative breast cancer, including race , 2009, Cancer Causes & Control.

[28]  K. Dookeran,et al.  Racial and Ethnic Differences in Breast Cancer Survival: How Much Is Explained by Screening, Tumor Severity, Biology, Treatment, Comorbidities, and Demographics? , 2008 .

[29]  Samuel Leung,et al.  Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype , 2008, Clinical Cancer Research.

[30]  R. Coates,et al.  Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA , 2008, Breast Cancer Research and Treatment.

[31]  C. Nielson,et al.  Breast Cancer among Hispanic and non-Hispanic White Women in Arizona , 2007, Journal of health care for the poor and underserved.

[32]  D. Sinha.  Dynamic Regression Models for Survival Data , 2007 .

[33]  Marc Tischkowitz,et al.  Use of immunohistochemical markers can refine prognosis in triple negative breast cancer , 2007, BMC Cancer.

[34]  A. Sauaia,et al.  Does having insurance affect differences in clinical presentation between Hispanic and non‐Hispanic white women with breast cancer? , 2007, Cancer.

[35]  R. Wolff,et al.  Genetic Admixture among Hispanics and Candidate Gene Polymorphisms: Potential for Confounding in a Breast Cancer Study? , 2007, Cancer Epidemiology Biomarkers & Prevention.

[36]  A. Fagerlin,et al.  The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. , 2006, American journal of public health.

[37]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[38]  Torben Martinussen,et al.  Dynamic Regression Models for Survival Data , 2006 .

[39]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[40]  R. Demicheli,et al.  Comment to Anderson WF, Jatoi I, Devesa SS: Distinct Breast Cancer Incidence and Prognostic Patterns in the NCI’s SEER Program: Suggesting a Possible Link Between Etiology and Outcome. Breast Cancer Res Treat 90:127–137, 2005 , 2006, Breast Cancer Research and Treatment.

[41]  A. Neugut,et al.  Hormone receptor status and survival in a population‐based cohort of patients with breast carcinoma , 2005, Cancer.

[42]  S. Devesa,et al.  Distinct breast cancer incidence and prognostic patterns in the NCI’s SEER program: suggesting a possible link between etiology and outcome , 2005, Breast Cancer Research and Treatment.

[43]  R. Baumgartner,et al.  Association of body composition and weight history with breast cancer prognostic markers: divergent pattern for Hispanic and non-Hispanic White women. , 2004, American journal of epidemiology.

[44]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[45]  M. Lippman,et al.  Breast Cancer Research and Treatment , 2004, Breast Cancer Research and Treatment.

[46]  F. Gilliland,et al.  Adiposity and sex hormones in postmenopausal breast cancer survivors. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  D. West,et al.  Socioeconomic status and breast carcinoma survival in four racial/ethnic groups , 2003, Cancer.

[48]  K. Malone,et al.  Differences in breast cancer stage, treatment, and survival by race and ethnicity. , 2003, Archives of internal medicine.

[49]  V. Shavers,et al.  Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35 , 2003, Cancer.

[50]  J. Samet,et al.  Hormone replacement therapy and breast carcinoma risk in Hispanic and non‐Hispanic women , 2002, Cancer.

[51]  S. Costa,et al.  Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-up. , 2002, European journal of cancer.

[52]  K. Malone,et al.  Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[53]  B. Hankey,et al.  Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. , 2002, American journal of epidemiology.

[54]  R. Gray.  Modeling Survival Data: Extending the Cox Model , 2002 .

[55]  R. Brant,et al.  Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. , 2001, JAMA.

[56]  P. Grambsch,et al.  Modeling Survival Data: Extending the Cox Model , 2000 .

[57]  R. Smith,et al.  Breast cancer epidemiology. , 2018 .

[58]  D. Kleinbaum.  Survival Analysis: A Self-Learning Text , 1997 .

[59]  F. Gilliland,et al.  Breast cancer survival among New Mexico Hispanic, American Indian, and non-Hispanic white women (1973-1992). , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[60]  S. Pocock,et al.  Regression Models and Non‐Proportional Hazards in the Analysis of Breast Cancer Survival , 1984 .

[61]  C. Meijer,et al.  Estrogen receptors in human breast cancer , 1982 .

[62]  W. McGuire.  Estrogen receptors in human breast cancer. , 1973, The Journal of clinical investigation.